title: [Immunostimulants--therapeutic aspects].
abstract: A survey is given about the so far known mode of action and the therapeutic application of the following agents with immunostimulatory effects: Interleukin-2, Interferon-gamma, Tumor necrosis factor, Thymosin alpha 1, Thymopentin, Splenopentin, Thymulin, Thymostimulin, Muramyl dipeptide, Bestatin, Tuftsin and Levamisole. The treatment of patients suffering from immunodeficiency disorders and cancer with such agents seems to be possible in the near future.
authors.affiliation: Klinik und Poliklinik für Hautkrankheiten, Humboldt-Universität zu Berlin.
authors.forename: W
authors.initials: W
authors.lastname: Diezel
authors.forename: H D
authors.initials: HD
authors.lastname: Volk
authors.forename: V
authors.initials: V
authors.lastname: Daniel
authors.forename: S
authors.initials: S
authors.lastname: Gruner
authors.forename: N
authors.initials: N
authors.lastname: Sönnichsen
mesh_terms: D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000627:therapeutic use; D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D006801:Humans; D007371:Interferon-gamma / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D007930:Leucine / Q000031:analogs & derivatives / Q000627:therapeutic use; D013951:Thymus Hormones / Q000627:therapeutic use; D014405:Tuftsin / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000627:therapeutic use
chemical_list: D000276:Adjuvants, Immunologic; D007376:Interleukin-2; D013951:Thymus Hormones; D014409:Tumor Necrosis Factor-alpha; D000119:Acetylmuramyl-Alanyl-Isoglutamine; D007371:Interferon-gamma; D007930:Leucine; C012211:ubenimex; D014405:Tuftsin
vernacular_title: Immunostimulantien--Therapeutische Aspekte.